Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients
Author:
Affiliation:
1. Department of Urology; Jichi Medical University Saitama Medical Center; Saitama Japan
2. Department of Radiology; Jichi Medical University Saitama Medical Center; Saitama Japan
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13465/fullpdf
Reference35 articles.
1. International variation in prostate cancer incidence and mortality rates;Center;Eur Urol,2012
2. Screening for prostate cancer: results of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer;Roobol;Eur Urol,2013
3. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies;Pokorny;Eur Urol,2014
4. Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases;Pinkhasov;BJU Int,2012
Cited by 275 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Model for Predicting Clinically Significant Prostate Cancer Using Prostate MRI and Risk Factors;Journal of the American College of Radiology;2024-09
2. Precision in prostate cancer detection: integrating prostate-specific antigen density (PSAD) and the Prostate Imaging Reporting and Data System (PI-RADS) to provide additional risk stratification for a more accurate diagnostic decision;Irish Journal of Medical Science (1971 -);2024-08-02
3. Integration of PSAd and multiparametric MRI to forecast biopsy outcomes in biopsy-naïve patients with PSA 4~20 ng/ml;Frontiers in Oncology;2024-07-04
4. Risk-Adapted Strategy Combining Magnetic Resonance Imaging and Prostate-Specific Antigen Density to Individualize Biopsy Decision in Patients With PI-RADS 3 ``Gray Zone'' Lesions;Clinical Genitourinary Cancer;2024-06
5. A nomogram to predict the absence of clinically significant prostate cancer in males with negative MRI;International braz j urol;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3